Although the cause and exact mechanism of S100A6 secretion into the bloodstream is not fully understood, different studies revealed elevated serum levels of S100A6 in NSCLC, gastric cancer and urothelial carcinoma [38–40] and suggested its role as a diagnostic and/or prognostic biomarker. Here, S100A6 is linked to non-small cell lung carcinoma.